The non-synonymous mutations and genetic variants rs1369481, rs895521, and rs17024926 in the NPAS2 gene were found significantly associated with susceptibility to prostate cancer, considering overall risk and risk of aggressive disease [118]. The gene discussed is NPAS2; the disease is prostate carcinoma.